Pharmacist intervention in treatment of patients with genotype 1 chronic hepatitis C.
作者信息
Marino Eduardo L, Alvarez-Rubio Luis, Miro Silvia, Modamio Pilar, Banos Fernando, Lastra Cecilia F, Alberdi-Leniz Aintzane
机构信息
Department of Pharmacy and Pharmaceutical Technology, University of Barcelona, Faculty of Pharmacy. Av. Joan XXIII s/n, Barcelona, Spain 08028.
出版信息
J Manag Care Pharm. 2009 Mar;15(2):147-50. doi: 10.18553/jmcp.2009.15.2.147.
Abstract
摘要
相似文献
1
Pharmacist intervention in treatment of patients with genotype 1 chronic hepatitis C.
J Manag Care Pharm. 2009 Mar;15(2):147-50. doi: 10.18553/jmcp.2009.15.2.147.
2
Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: a prospective, real-life, observational study.
World J Gastroenterol. 2008 Oct 28;14(40):6195-203. doi: 10.3748/wjg.14.6195.
3
[Importance of medication adherence to peginterferon-ribavirin combination therapy in patients with chronic hepatitis C].
Korean J Gastroenterol. 2011 May 25;57(5):294-301. doi: 10.4166/kjg.2011.57.5.294.
4
[Therapy of chronic Hepatitis C in 2008].
MMW Fortschr Med. 2008 Mar 27;150(13):31-4. doi: 10.1007/BF03365407.
5
Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype.
J Gastroenterol Hepatol. 2013 Mar;28(3):443-9. doi: 10.1111/jgh.12039.
6
Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation.
Health Technol Assess. 2006 Jul;10(21):1-113, iii. doi: 10.3310/hta10210.
7
Addicts with chronic hepatitis C: difficult to reach, manage or treat?
World J Gastroenterol. 2013 Nov 28;19(44):8011-9. doi: 10.3748/wjg.v19.i44.8011.
8
Multicenter study on the discontinuation and efficacy of chronic hepatitis C treatment in the Spanish penitentiary population (EPIBAND study).
Eur J Gastroenterol Hepatol. 2014 Oct;26(10):1083-9. doi: 10.1097/MEG.0000000000000163.
9
Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan.
World J Gastroenterol. 2008 Dec 21;14(47):7225-4230. doi: 10.3748/wjg.14.7225.
10
Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.
Health Technol Assess. 2004 Oct;8(39):iii-iv, 1-125. doi: 10.3310/hta8390.
引用本文的文献
1
Outcomes of a Pharmacist-Led Hepatitis C Virus Treatment Program in an Urban Safety-Net Health System, Chicago, 2017-2019.
Public Health Rep. 2022 Jul-Aug;137(4):702-710. doi: 10.1177/00333549211015664. Epub 2021 May 27.
2
A Randomized Controlled Trial to Assess the Impact of Clinical Pharmacy Interventions on Treatment Outcomes, Health Related Quality of Life and Medication Adherence Among Hepatitis C Patients.
Patient Prefer Adherence. 2019 Dec 13;13:2089-2100. doi: 10.2147/PPA.S224937. eCollection 2019.
3
Role of a clinical pharmacist as part of a multidisciplinary care team in the treatment of HCV in patients living with HIV/HCV coinfection.
Integr Pharm Res Pract. 2018 Aug 28;7:105-111. doi: 10.2147/IPRP.S169282. eCollection 2018.
4
Outcomes of Pharmacy-Led Hepatitis C Direct-Acting Antiviral Utilization Management at a Veterans Affairs Medical Center.
J Manag Care Spec Pharm. 2017 Mar;23(3):364-369. doi: 10.18553/jmcp.2017.23.3.364.
5
Impact of Clinical Pharmacy Specialists on the Design and Implementation of a Quality Improvement Initiative to Decrease Inappropriate Medications in a Veterans Affairs Emergency Department.
J Manag Care Spec Pharm. 2016 Jan;22(1):74-80. doi: 10.18553/jmcp.2016.22.1.74.
6
Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum.
Int J Drug Policy. 2015 Oct;26(10):922-35. doi: 10.1016/j.drugpo.2015.05.002. Epub 2015 May 17.
7
Influence of treatment complexity on adherence and incidence of blips in HIV/HCV coinfected patients.
J Manag Care Spec Pharm. 2015 Feb;21(2):153-7. doi: 10.18553/jmcp.2015.21.2.153.
8
Adherence: a review of education, research, practice and policy in Spain.
Pharm Pract (Granada). 2009 Jul;7(3):125-38. doi: 10.4321/s1886-36552009000300001. Epub 2009 Mar 15.
9
Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute?
J Consult Clin Psychol. 2013 Apr;81(2):361-74. doi: 10.1037/a0029030. Epub 2012 Jun 25.
Zotero 插件